5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases
- 1 May 1977
- Vol. 39 (5) , 1936-1939
- https://doi.org/10.1002/1097-0142(197705)39:5<1936::aid-cncr2820390504>3.0.co;2-n
Abstract
Twenty-one patients with biopsy-proven hepatocellular carcinoma were treated with oral or intravenous 5-Fluorouracil according to a ramdomized treatment schedule. Twenty-one patients were evaluable for response and toxicity. The two groups were comparable in distribution of pretreatment characteristics. There were no objective responses in either group. This is the largest reported group of patients with hepatocellular carcinoma treated with 5-Fluorouracil. Toxicity occurred in 46% of patients treated, but was tolerable. In contrast to previous reports,11,13 we have found that weekly 5-Fluorouracil given orally or intravenously is not of significant value in the treatment of hepatocellular carcinoma.This publication has 11 references indexed in Scilit:
- Liver-Cell Adenomas Associated with Use of Oral ContraceptivesNew England Journal of Medicine, 1976
- Hepatic Changes in Young Women Ingesting Contraceptive SteroidsPublished by American Medical Association (AMA) ,1976
- Metabolic studies of 5-fluorouracil—II. Influences of the route of administration on the dynamics of distribution in manCancer, 1974
- Clinical manifestations of hepatomaThe American Journal of Medicine, 1974
- Adenocarcinomas of stomach, pancreas, liver, and biliary tracts.Survival of 328 patients treated with fluoropyrimidine therapyCancer, 1974
- Primary malignant tumors of the liverCancer, 1971
- 5-fluorouracil given once weekly: Comparison of intravenous and oral administrationCancer, 1971
- Single Agents in Cancer ChemotherapyPublished by Springer Nature ,1970
- Treatment of cancer with weekly intravenous 5-fluorouracilCancer, 1968
- AN ANALYSIS OF 62 CASES OF PRIMARY CARCINOMA OF THE LIVER BASED ON 24,400 NECROPSIES AT BELLEVUE HOSPITALAnnals of Internal Medicine, 1937